169(top 1%)
PR articles
16.5K(top 1%)
PR citations
63(top 1%)
PR h-index
66(top 1%)
h-index
193
documents
20.6K
doc citations
3.7K
citing journals
100
times ranked

Publications

173 peer-reviewed articles • 18,204 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Challenges of cancer registration and epidemiology in Italy
Cancer Epidemiology, 2025, 96, 102804
1.68Citations (PDF)
2Incidence and survival of rare female genital tract cancers in Europe: The EUROCARE-6 study
European Journal of Surgical Oncology, 2025, 51, 109996
1.54Citations (PDF)
3Protocol for investigating data quality and reporting outcomes of pediatric gliomas in population-based cancer registry research
STAR Protocols, 2024, 5, 102905
0.85Citations (PDF)
4A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data
BMC Medical Research Methodology, 2023, 23,
1.713Citations (PDF)
5Incidence Trends and Main Features of Gastro-Intestinal Stromal Tumours in a Mediterranean Region: A Population-Based Study
Cancers, 2023, 15, 2994
2.75Citations (PDF)
6Descriptive epidemiology of the head and neck cancers in old patients
Frontiers in Oncology, 2023, 13,
1.732Citations (PDF)
7Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage
Frontiers in Oncology, 2023, 13,
1.711Citations (PDF)
8Prediction of Risk of Metastatic Recurrence for Female Breast Cancer Patients in the Presence of Competing Causes of Death
Cancer Epidemiology Biomarkers and Prevention, 2023, 32, 1683-1689
0.64Citations (PDF)
9Estimating Country-Specific Incidence Rates of Rare Cancers: Comparative Performance Analysis of Modeling Approaches Using European Cancer Registry Data
American Journal of Epidemiology, 2022, 191, 487-498
2.46Citations (PDF)
10Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers
Cancer Epidemiology, 2022, 78, 102145
1.66Citations (PDF)
11Salmerón et al. Respond to “Future Directions for Predicting Rare Cancer Rates”
American Journal of Epidemiology, 2022, 191, 503-504
2.40Citations (PDF)
12Salivary gland cancers in elderly patients: challenges and therapeutic strategies
Frontiers in Oncology, 2022, 12,
1.717Citations (PDF)
13Variation of Cancer Incidence between and within GRELL Countries
International Journal of Environmental Research and Public Health, 2021, 18, 9262
2.06Citations (PDF)
14Major and minor salivary gland tumours
Critical Reviews in Oncology/Hematology, 2020, 152, 102959
3.580Citations (PDF)
15Incidence and Survival of Patients With Conjunctival Melanoma in Europe
JAMA Ophthalmology, 2020, 138, 601
4.652Citations (PDF)
16Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?
Pediatric Blood and Cancer, 2019, 66,
0.846Citations (PDF)
17The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
Clinical Lung Cancer, 2019, 20, e652-e660
2.19Citations (PDF)
18Changes in life expectancy for cancer patients over time since diagnosis
Journal of Advanced Research, 2019, 20, 153-159
7.433Citations (PDF)
19Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet
Frontiers in Oncology, 2019, 9,
1.720Citations (PDF)
20Incidence of rare cancers in the city of São Paulo, Brazil
Tumori, 2019, 105, 22-30
1.27Citations (PDF)
21The European study on centralisation of childhood cancer treatment
European Journal of Cancer, 2019, 115, 120-127
3.523Citations (PDF)
22Rare cancers in childhood and adolescence in Brazil: First report of data from 19 population‐based cancer registries
Cancer, 2019, 125, 2638-2646
2.713Citations (PDF)
23Excess risk of dying of other causes of cured cancer patients
Tumori, 2019, 105, 199-204
1.29Citations (PDF)
24Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors
European Journal of Cancer, 2019, 110, 120-126
3.598Citations (PDF)
25Treatment challenges in and outside a network setting: Soft tissue sarcomas
European Journal of Surgical Oncology, 2019, 45, 31-39
1.531Citations (PDF)
26Epidemiology of rare cancers and inequalities in oncologic outcomes
European Journal of Surgical Oncology, 2019, 45, 3-11
1.562Citations (PDF)
27Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
European Journal of Surgical Oncology, 2019, 45, 46-51
1.53Citations (PDF)
28Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
European Journal of Surgical Oncology, 2019, 45, 75-80
1.517Citations (PDF)
29Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
European Journal of Surgical Oncology, 2019, 45, 60-66
1.55Citations (PDF)
30Treatment challenges in and outside a network setting: Head and neck cancers
European Journal of Surgical Oncology, 2019, 45, 40-45
1.537Citations (PDF)
31Bayesian estimates of the incidence of rare cancers in Europe
Cancer Epidemiology, 2018, 54, 95-100
1.613Citations (PDF)
32Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Lancet, The, 2018, 391, 1023-1075
45.25,032Citations (PDF)
33Survival of adults with cancers of bone or soft tissue in Europe—Report from the EUROCARE-5 study
Cancer Epidemiology, 2018, 56, 146-153
1.643Citations (PDF)
34Mucosal melanoma of the head and neck
Critical Reviews in Oncology/Hematology, 2017, 112, 136-152
3.5171Citations (PDF)
35Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
Lancet Haematology,the, 2017, 4, e202-e217
7.4183Citations (PDF)
36Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
European Journal of Cancer, 2017, 77, 140-152
3.596Citations (PDF)
37Primary central nervous system lymphoma
Critical Reviews in Oncology/Hematology, 2017, 113, 97-110
3.586Citations (PDF)
38Central nervous system gliomas
Critical Reviews in Oncology/Hematology, 2017, 113, 213-234
3.5141Citations (PDF)
39Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
Gynecologic Oncology, 2017, 144, 396-404
2.3132Citations (PDF)
40The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Gynecologic Oncology, 2017, 144, 405-413
2.3117Citations (PDF)
41Cholangiocarcinoma
Critical Reviews in Oncology/Hematology, 2017, 116, 11-31
3.5117Citations (PDF)
42Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, 2017, 84, 335-353
3.543Citations (PDF)
43Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Lancet Oncology, The, 2017, 18, 1022-1039
14.5472Citations (PDF)
44Geographical variability in survival of European children with central nervous system tumours
European Journal of Cancer, 2017, 82, 137-148
3.548Citations (PDF)
45Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
Pediatric Blood and Cancer, 2017, 64,
0.834Citations (PDF)
46Changes in Mortality and Incidence of Prostate Cancer by Risk Class in Different Periods in Italy: The Possible Effects of PSA Spread
Tumori, 2017, 103, 292-298
1.24Citations (PDF)
47Childhood cancer and environmental integrity: a commentary and a proposal
Revista De Saude Publica, 2017, 51,
1.13Citations (PDF)
48Childhood medulloblastoma
Critical Reviews in Oncology/Hematology, 2016, 105, 35-51
3.5135Citations (PDF)
49Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines
Lancet Oncology, The, 2016, 17, e163-e172
14.592Citations (PDF)
50Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5
Lancet Oncology, The, 2016, 17, 896-906
14.5258Citations (PDF)
51Neuroblastoma (Peripheral neuroblastic tumours)
Critical Reviews in Oncology/Hematology, 2016, 107, 163-181
3.5122Citations (PDF)
52Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
European Journal of Cancer, 2016, 67, 91-98
3.518Citations (PDF)
53Thymoma and thymic carcinomas
Critical Reviews in Oncology/Hematology, 2016, 99, 332-350
3.5302Citations (PDF)
54Estimates of prostate cancer burden in Italy
Cancer Epidemiology, 2016, 40, 166-172
1.612Citations (PDF)
55Paranasal sinus cancer
Critical Reviews in Oncology/Hematology, 2016, 98, 45-61
3.548Citations (PDF)
56Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study
European Journal of Cancer, 2015, 51, 2206-2216
3.597Citations (PDF)
57Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study
European Journal of Cancer, 2015, 51, 2120-2129
3.575Citations (PDF)
58Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data
Annals of Oncology, 2015, 26, 1263-1268
8.186Citations (PDF)
59Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, 2015, 51, 2217-2230
3.586Citations (PDF)
60Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
European Journal of Cancer, 2015, 51, 2130-2143
3.5438Citations (PDF)
61Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
European Journal of Cancer, 2015, 51, 2144-2157
3.5157Citations (PDF)
62The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods
European Journal of Cancer, 2015, 51, 2104-2119
3.5117Citations (PDF)
63Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5
European Journal of Cancer, 2015, 51, 2169-2178
3.5135Citations (PDF)
64Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types
Annals of Oncology, 2014, 25, 2251-2260
8.189Citations (PDF)
65Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
Lancet Oncology, The, 2014, 15, 35-47
14.5990Citations (PDF)
66Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project
Cancer Epidemiology, 2013, 37, 850-856
1.624Citations (PDF)
67Cancer prevalence estimates in Europe at the beginning of 2000
Annals of Oncology, 2013, 24, 1660-1666
8.137Citations (PDF)
68Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study
BMJ Open, 2013, 3, e003055
1.276Citations (PDF)
69Variations in Cancer Survival and Patterns of Care Across Europe: Roles of Wealth and Health-Care Organization
Journal of the National Cancer Institute Monographs, 2013, 2013, 79-87
1.841Citations (PDF)
70Comparing Cancer Care, Outcomes, and Costs Across Health Systems: Charting the Course
Journal of the National Cancer Institute Monographs, 2013, 2013, 124-130
1.832Citations (PDF)
71Estimates of cancer burden in Lombardy
Tumori, 2013, 99, 277-284
1.21Citations (PDF)
72Cancer Burden Estimates and Forecasts: Uses and Cautions
Tumori, 2013, 99, 439-443
1.28Citations (PDF)
73Rare cancers of the head and neck area in Europe
European Journal of Cancer, 2012, 48, 783-796
3.563Citations (PDF)
74Incidence and survival of rare urogenital cancers in Europe
European Journal of Cancer, 2012, 48, 456-464
3.5157Citations (PDF)
75Embryonal cancers in Europe
European Journal of Cancer, 2012, 48, 1425-1433
3.544Citations (PDF)
76The Burden of Rare Cancers in Italy: The Surveillance of Rare Cancers in Italy (RITA) Project
Tumori, 2012, 98, 550-558
1.214Citations (PDF)
77Rare cancers are not so rare: The rare cancer burden in Europe
European Journal of Cancer, 2011, 47, 2493-2511
3.5760Citations (PDF)
78Childhood medulloblastoma
Critical Reviews in Oncology/Hematology, 2011, 79, 65-83
3.559Citations (PDF)
79Prognoses for head and neck cancers in Europe diagnosed in 1995–1999: a population-based study
Annals of Oncology, 2011, 22, 165-174
8.137Citations (PDF)
80European disparities in malignant digestive endocrine tumours survival
International Journal of Cancer, 2010, 126, 2928-2934
2.869Citations (PDF)
81Major and minor salivary gland tumors
Critical Reviews in Oncology/Hematology, 2010, 74, 134-148
3.5473Citations (PDF)
82Colon cancer
Critical Reviews in Oncology/Hematology, 2010, 74, 106-133
3.5394Citations (PDF)
83Patterns of care for European colorectal cancer patients diagnosed 1996–1998: A EUROCARE High Resolution Study
Acta Oncológica, 2010, 49, 776-783
1.458Citations (PDF)
84Survival for ethmoid sinus adenocarcinoma in European populations
Acta Oncológica, 2009, 48, 992-998
1.424Citations (PDF)
85Prostate cancer treatment in Europe at the end of 1990s
Acta Oncológica, 2009, 48, 867-873
1.411Citations (PDF)
86Survival from salivary glands adenoid cystic carcinoma in European populations
Oral Oncology, 2009, 45, 669-674
1.5107Citations (PDF)
87Cholangiocarcinoma
Critical Reviews in Oncology/Hematology, 2009, 69, 259-270
3.5165Citations (PDF)
88Rectal cancer
Critical Reviews in Oncology/Hematology, 2009, 70, 160-182
3.515Citations (PDF)
89Gastric cancer
Critical Reviews in Oncology/Hematology, 2009, 71, 127-164
3.5362Citations (PDF)
90Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET)
Critical Reviews in Oncology/Hematology, 2009, 71, 165-179
3.562Citations (PDF)
91Long-term survival expectations of cancer patients in Europe in 2000–2002
European Journal of Cancer, 2009, 45, 1028-1041
3.590Citations (PDF)
92The advantage of women in cancer survival: An analysis of EUROCARE-4 data
European Journal of Cancer, 2009, 45, 1017-1027
3.5263Citations (PDF)
93The cure of cancer: A European perspective
European Journal of Cancer, 2009, 45, 1067-1079
3.586Citations (PDF)
94Survival of European children and young adults with cancer diagnosed 1995–2002
European Journal of Cancer, 2009, 45, 992-1005
3.5478Citations (PDF)
95Oligodendroglioma
Critical Reviews in Oncology/Hematology, 2008, 66, 262-272
3.580Citations (PDF)
96Glioblastoma in adults
Critical Reviews in Oncology/Hematology, 2008, 67, 139-152
3.5164Citations (PDF)
97Cancer survival in five continents: a worldwide population-based study (CONCORD)
Lancet Oncology, The, 2008, 9, 730-756
14.51,141Citations (PDF)
98Human Papillomavirus in HNSCC: A European Epidemiologic Perspective
Hematology/Oncology Clinics of North America, 2008, 22, 1143-1153
1.541Citations (PDF)
99Survival in Patients With Uveal Melanoma in Europe
JAMA Ophthalmology, 2008, 126, 1413
2.2109Citations (PDF)
100Incidence of Uveal Melanoma in Europe
Ophthalmology, 2007, 114, 2309-2315.e2
5.9425Citations (PDF)
101Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Lancet Oncology, The, 2007, 8, 784-796
14.5848Citations (PDF)
102Anaplastic astrocytoma in adults
Critical Reviews in Oncology/Hematology, 2007, 63, 72-80
3.570Citations (PDF)
103Ependymoma
Critical Reviews in Oncology/Hematology, 2007, 63, 81-89
3.5166Citations (PDF)
104Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study
Journal of Cancer Survivorship, 2007, 1, 247-254
1.414Citations (PDF)
105Renal cancer
Critical Reviews in Oncology/Hematology, 2007, 64, 247-262
3.536Citations (PDF)
106Survival from rare cancer in adults: a population-based study
Lancet Oncology, The, 2006, 7, 132-140
14.5127Citations (PDF)
107Incidence of and survival from Wilms’ tumour in adults in Europe: Data from the EUROCARE study
European Journal of Cancer, 2006, 42, 2363-2368
3.572Citations (PDF)
108Ovarian cancer
Critical Reviews in Oncology/Hematology, 2006, 60, 159-179
3.5214Citations (PDF)
109Gastric cancer
Critical Reviews in Oncology/Hematology, 2005, 54, 209-241
3.582Citations (PDF)
110Germ cell tumours of the testis
Critical Reviews in Oncology/Hematology, 2005, 53, 141-164
3.578Citations (PDF)
111Cancer of the penis
Critical Reviews in Oncology/Hematology, 2005, 53, 165-177
3.590Citations (PDF)
112Cancer of the prostate
Critical Reviews in Oncology/Hematology, 2005, 56, 379-396
3.595Citations (PDF)
113Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
Journal of Clinical Oncology, 2005, 23, 3742-3751
12.3288Citations (PDF)
114Colon cancer prevalence and estimation of differing care needs of colon cancer patients
Annals of Oncology, 2004, 15, 1136-1142
8.123Citations (PDF)
115Adult acute myeloid leukaemia
Critical Reviews in Oncology/Hematology, 2004, 50, 197-222
3.5144Citations (PDF)
116Adult acute lymphoblastic leukaemia
Critical Reviews in Oncology/Hematology, 2004, 50, 223-261
3.579Citations (PDF)
117Colon cancer
Critical Reviews in Oncology/Hematology, 2004, 51, 145-170
3.533Citations (PDF)
118Cancer of pancreas
Critical Reviews in Oncology/Hematology, 2004, 50, 147-155
3.521Citations (PDF)
119Explaining gastric cancer survival differences among European countries
International Journal of Cancer, 2004, 109, 737-741
2.878Citations (PDF)
120Rectal cancer
Critical Reviews in Oncology/Hematology, 2004, 51, 121-143
3.58Citations (PDF)
121Cancer of the nasopharynx
Critical Reviews in Oncology/Hematology, 2003, 45, 199-214
3.555Citations (PDF)
122Cancer of the larynx
Critical Reviews in Oncology/Hematology, 2003, 47, 65-80
3.5104Citations (PDF)
123Cancer survival in European adolescents and young adults
European Journal of Cancer, 2003, 39, 2600-2610
3.587Citations (PDF)
124Comparison of stomach cancer incidence and survival in four continents
European Journal of Cancer, 2003, 39, 1603-1609
3.5104Citations (PDF)
125Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology
European Journal of Cancer, 2003, 39, 2214-2222
3.5108Citations (PDF)
126EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Annals of Oncology, 2003, 14, v61-v118
8.1654Citations (PDF)
127EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Annals of Oncology, 2003, 14, v128-v149
8.1416Citations (PDF)
128The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis
Annals of Oncology, 2003, 14, v14-v27
8.174Citations (PDF)
129Childhood cancer survival in Europe
Annals of Oncology, 2003, 14, v119-v127
8.1120Citations (PDF)
130Cancer prevalence in European registry areas
Annals of Oncology, 2002, 13, 840-865
8.1166Citations (PDF)
131Childhood cancer survival in Europe and the United States
Cancer, 2002, 95, 1767-1772
2.7233Citations (PDF)
132Bladder cancer
Critical Reviews in Oncology/Hematology, 2002, 41, 89-106
3.538Citations (PDF)
133Childhood melanoma in Europe since 1978
European Journal of Cancer, 2001, 37, 780-784
3.564Citations (PDF)
134The EUROCARE study of survival of cancer patients in Europe
European Journal of Cancer, 2001, 37, 673-677
3.534Citations (PDF)
135Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978–1992
European Journal of Cancer, 2001, 37, 687-694
3.533Citations (PDF)
136Childhood malignancies in the EUROCARE study
European Journal of Cancer, 2001, 37, 678-686
3.534Citations (PDF)
137Childhood cancer survival in Europe
European Journal of Cancer, 2001, 37, 810-816
3.543Citations (PDF)
138Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978
European Journal of Cancer, 2001, 37, 695-702
3.516Citations (PDF)
139Incidence and prevalence of all cancerous diseases in Italy
European Journal of Cancer, 2001, 37, 1149-1157
3.523Citations (PDF)
140Cancer survival increases in Europe, but international differences remain wide
European Journal of Cancer, 2001, 37, 1659-1667
3.5139Citations (PDF)
141Survival for colorectal cancer Reply
Gut, 2001, 48, 868-869
10.41Citations (PDF)
142Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study
Gut, 2000, 47, 533-538
10.4242Citations (PDF)
143The Prevalence of Colorectal Cancer in Italy
Tumori, 1999, 85, 387-390
1.27Citations (PDF)
144Title is missing!
Cancer Causes and Control, 1999, 10, 575-581
1.222Citations (PDF)
145The cure for colon cancer: Results from the EUROCARE study
International Journal of Cancer, 1998, 77, 322-329
2.881Citations (PDF)
146Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country
1998, 77, 679-683
83Citations (PDF)
147Variation in survival of patients with lung cancer in Europe, 1985–1989
European Journal of Cancer, 1998, 34, 2191-2196
3.5137Citations (PDF)
148The prognostic role of gender in survival of adult cancer patients
European Journal of Cancer, 1998, 34, 2271-2278
3.5142Citations (PDF)
149Survival of European women with gynaecological tumours, during the period 1978–1989
European Journal of Cancer, 1998, 34, 2218-2225
3.581Citations (PDF)
150Survival of colorectal cancer patients in Europe during the period 1978–1989
European Journal of Cancer, 1998, 34, 2176-2183
3.5134Citations (PDF)
151Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours
European Journal of Cancer, 1998, 34, 2154-2161
3.5103Citations (PDF)
152Survival of patients with oesophageal and gastric cancers in Europe
European Journal of Cancer, 1998, 34, 2167-2175
3.5110Citations (PDF)
153Trends of Colorectal Cancer Incidence and Prevalence in Italian Regions
Tumori, 1998, 84, 1-8
1.210Citations (PDF)
154Estimation and projections of colorectal cancer trends in Italy
International Journal of Epidemiology, 1997, 26, 924-932
2.829Citations (PDF)
155Studying Survival of Cancer Patients in Different Populations: Its Potential and Role
Tumori, 1997, 83, 3-8
1.220Citations (PDF)
156Breast Cancer Prevalence Measured by the Lombardy Cancer Registry
Tumori, 1997, 83, 875-879
1.27Citations (PDF)
157The Itacare Study
Tumori, 1997, 83, 17-24
1.210Citations (PDF)
158Variations in the Survival of Adult Cancer Patients in Italy
Tumori, 1997, 83, 497-504
1.229Citations (PDF)
159Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987
European Journal of Cancer, 1996, 32, 831-835
3.541Citations (PDF)
160Comparisons of colon–cancer survival among european countries: The eurocare study
International Journal of Cancer, 1995, 63, 43-48
2.865Citations (PDF)
161Estimation and projections of stomach cancer trends in Italy
Cancer Causes and Control, 1995, 6, 339-346
1.223Citations (PDF)
162Time trends of lung and larynx cancers in Italy
International Journal of Cancer, 1994, 57, 154-161
2.833Citations (PDF)
163Estimated Incidence and Prevalence of Female Breast Cancer in Italian Regions
Tumori, 1992, 78, 13-21
1.226Citations (PDF)
164Survival for lung cancer in northern Italy
Cancer Causes and Control, 1992, 3, 223-230
1.215Citations (PDF)
165Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study
Cancer, 1992, 69, 626-635
2.7103Citations (PDF)
166Survival and age at diagnosis of breast cancer in a population-based cancer registry
European Journal of Cancer & Clinical Oncology, 1991, 27, 981-984
0.755Citations (PDF)
167Breast cancer incidence and prevalence estimated from survival and mortality
Cancer Causes and Control, 1990, 1, 23-29
1.245Citations (PDF)
168Incident Lung Cancer Survival. Long-Term Follow-Up of a Population-Based Study in Italy
Tumori, 1990, 76, 199-204
1.226Citations (PDF)
169Letter to the editor
International Journal of Cancer, 1989, 44, 186-187
2.86Citations (PDF)
170Title is missing!
0
2Citations (PDF)
171Title is missing!
0
0Citations (PDF)
172The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation
American Journal of Epidemiology, 0, 194, 3316-3324
2.41Citations (PDF)
173Neuroblastoma by Stage at Diagnosis and Other Prognostic Factors: The Results of the BENCHISTA Italian Project—A Population-Based Study
Cancers, 0, 18, 613
2.70Citations (PDF)